Private Equity
Shardul Amarchand Mangaldas & Co. Advises SageOne Investment Managers and its Founder Samit Vartak on Acquisition by ASK Asset Management
The acquisition brings together two established investment management platforms with complementary synergies. As part of the transaction, Mr. Samit Vartak will be appointed as Chief Investment Officer — Equities at ASK IM for the combined business.
Shardul Amarchand Mangaldas & Co. Advises Mubadala Investment Company on Divestment of its Stake in Cube Highways Trust
The divestment was undertaken through on-market block trades on the stock exchanges pursuant to an accelerated bookbuild process, with the units acquired by a range of institutional investors.
Cyril Amarchand Mangaldas advises TA Associates on the India-leg of the strategic investment in Oxane Partners Limited
The Oxane Partners group is engaged in the business of providing technology-enabled solutions for private credit markets.
Shardul Amarchand Mangaldas & Co. Advises ChrysCapital Group on acquisition of stake in Linux Laboratories Pvt. Ltd.
The transaction comprises of a secondary acquisition of shares from the Promoters and Tata Capital Healthcare Fund II and, a primary subscription to shares proposed to be issued by the Target Company.
Swathi Girimaji Joins S&R Associates as Partner in Bengaluru
Swathi Girimaji’s practice covers mergers and acquisitions, venture capital investments, private equity and general corporate matters, including significant experience in the technology, education, health tech, fintech and consumer sectors.
CAM advises Cerberus Capital Management on the Indian legal aspects of its GBP 1.1 Billion acquisition of Goodwin
The Transaction is expected to close in Q1 2027, subject to receipt of required regulatory approvals and satisfaction of other customary closing conditions.
Cyril Amarchand Mangaldas advises on investment in Piramal Finance Limited
CAM’s role included advising and assisting with the structuring and compliances with applicable legal and regulatory requirements as well as drafting and finalising of documents, disclosures and filings, in relation to the Preferential Issue.
CAM advises International Finance Corporation in relation to its proposed follow-on investment in Mahindra Last Mile Mobility Ltd., a subsidiary of Mahindra & Mahindra
The Transaction is proposed to be completed in tranches and remains subject to regulatory approvals.
Khaitan & Co Advises India Resurgence Fund on Acquisition of Majority Stake in Fine Edge Engineering
Khaitan & Co advised India Resurgence Fund, on its acquisition of a significant majority stake in Fine Edge Engineering Private Limited (housing the precision machined castings business of Ashok Iron Works Group).
Cyril Amarchand Mangaldas advises Warburg Pincus LLC on the sale of its shares in IndiaFirst Life Insurance Company Ltd. to BNP Paribas Cardif
The Company is a private life insurer registered with the Insurance Regulatory and Development Authority of India (“IRDAI”). The other shareholders of the Company include Bank of Baroda and Union Bank of India.
Cyril Amarchand Mangaldas advises Cornerstone Ventures Enterprise Tech Fund II on its investment in Groyyo Private Ltd.
Cyril Amarchand Mangaldas advised Cornerstone Ventures Enterprise Tech Fund II on its investment in Groyyo Private Limited.
Cyril Amarchand Mangaldas represents Medicover on its € 1.2 billion sale of 100% stake in Sahrudaya Health Care Private Ltd. to KKR
The Seller, a holding company of Medicover held ~65% in SHCPL, and SHCPL in turn has 5 subsidiaries which together operate 26 hospitals across Telangana, Andhra Pradesh, Karnataka and Maharashtra.
Cyril Amarchand Mangaldas represents Carpediem Capital Partners Fund II on its investment into IIRM Holdings India Ltd.
CAM advised on structuring the transaction and on drafting and finalising the transaction documents, including the corporate secretarial documents.
Cyril Amarchand Mangaldas advises Morgan Stanley on sale of shares of Shadowfax Technologies by Eight Roads Investments
Cyril Amarchand Mangaldas acted as Indian legal counsel to Morgan Stanley India in connection with the sale of 41.61 million equity shares of Shadowfax Technologies Limited by Eight Roads Investments Mauritius II Limited for an aggregate consideration of ₹852.55 crore through screen-based trades on the NSE and BSE on July 24, 2026.
CAM dvises TPG on its acquisition of 100% of share capital of Aseem Infrastructure Finance Ltd.
CAM acted as legal counsel to TPG in connection with its acquisition of 100% of the share capital of Aseem Infrastructure Finance Limited (AIFL).
Cyril Amarchand Mangaldas advises Accel on follow-on investment in FirstClub’s Series B round
FirstClub engages in the business of wholesale trading including sale of goods and merchandise through both online and offline channels.
Shardul Amarchand Mangaldas & Co. advises Prosus on Series B Investment in Equal Identity Private Ltd.
Founded by Keshav Reddy, Equal AI started as a data-sharing and identity infrastructure company before entering the business of consumer AI systems in October, 2025. The Company’s AI caller assistant solution enables users to screen spam calls, identify callers, understand call intent and perform actions on behalf of users.
CAM acts as legal counsel to Bessemer Venture Partners in relation to its participation in Series B fund-raise by Axonwise Private Ltd.
Sarvam AI is developing a full-stack, sovereign AI platform custom-tailored for Indian languages, data, and governance.
Cyril Amarchand Mangaldas Advises Peak XV on their acquisition of stake in Plum Benefits Private Limited
Advice is regarding its acquisition of stake in Plum Benefits Private Limited through subscription and secondary purchase of compulsorily convertible preference shares. The transaction included regulatory advisory concerning Plum Benefits and its IRDAI-registered insurance broking subsidiary.